Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use

Objectives: C1q is a valuable biomarker of disease activity in systemic lupus erythematosus (SLE). The “gold standard” assay, rocket immunoelectrophoresis (RIE), is time-consuming, and thus a shift to soluble immune precipitation techniques such as nephelometry has occurred. However, quantification...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Immunol
Главные авторы: Sandholm, Kerstin, Persson, Barbro, Skattum, Lillemor, Eggertsen, Gösta, Nyman, Dag, Gunnarsson, Iva, Svenungson, Elisabet, Nilsson, Bo, Ekdahl, Kristina N.
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2019
Предметы:
Immunology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357986/
https://ncbi.nlm.nih.gov/pubmed/30740097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.00007
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы